LAURIE LETIZIA: Open Payments
NPI 1245596600 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 45 payments from 16 companies in 2025. Trend: 2023 $1,249 · 2024 $492 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $262 |
| ABBVIE INC. | 9 | $166 |
| Celltrion USA Inc. | 2 | $152 |
| Regeneron Healthcare Solutions, Inc. | 1 | $127 |
| Janssen Biotech, Inc. | 4 | $84 |
| Novo Nordisk Inc | 4 | $82 |
| Intercept Pharmaceuticals, Inc. | 4 | $73 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Ardelyx, Inc. | 2 | $42 |
Products named: REZDIFFRA, DUPIXENT, ZYMFENTRA, TREMFYA, LINZESS, Wegovy, OCALIVA, VERQUVO.
Industry payments across FL — which companies pay providers there.
